Walk into Huskie Stadium in DeKalb, and the impact that Jeff Yordon has had on NIU athletics is unmistakable. The Jeffrey and Kimberly Yordon Academic and Athletic Performance Center opened its door in 2007 and instantly transformed the educational environment for nearly 500 student-athletes both on the field and in the classroom.
A letter-winner in football and track, Yordon has had an extraordinarily successful career in the pharmaceutical business over the past 35 years. Recognized internationally for his knowledge and experience, he is currently the Chief Executive Officer of Sagent Pharmaceuticals, a specialty manufacturer of quality injectable products, which he founded in 2006.
Under his leadership, Sagent has created a unique, global network of resources, comprising an advanced development network of more than 30 partners, an unparalleled breadth and depth in product manufacturing with more than 60 facilities and access to advanced scientific resources with more than 2,500 R&D employees worldwide. The company currently has more than 200 products in development.
Before founding Sagent Pharmaceuticals, Yordon held senior level executive positions with a wide variety of pharmaceutical companies including American Pharmaceutical Partners, where he was president and chief operating officer.
Yordon is an active member of the University’s Foundation Board and NIU Executive Club Board in addition to being an Alumni Advisor to the Athletic Department. He received a Distinguished Alumni Award in 2007.